Aptamer-labeled PLGA nanoparticles for targeting cancer cells.
- Published in:
- Cancer Nanotechnology (1868-6958), 2012, v. 3, n. 1-6, p. 1, doi. 10.1007/s12645-011-0024-6
- By:
- Publication type:
- Article
Works matching IS 18686958 AND DT 2012 AND VI 3 AND IP 1-6
Results: 7
1
2
PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy.
- Published in:
- Cancer Nanotechnology (1868-6958), 2012, v. 3, n. 1-6, p. 25, doi. 10.1007/s12645-012-0027-y
- By:
- Publication type:
- Article
3
Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development.
- Published in:
- Cancer Nanotechnology (1868-6958), 2012, v. 3, n. 1-6, p. 13, doi. 10.1007/s12645-012-0026-z
- By:
- Publication type:
- Article
4
Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse.
- Published in:
- Cancer Nanotechnology (1868-6958), 2012, v. 3, n. 1-6, p. 47, doi. 10.1007/s12645-012-0029-9
- By:
- Publication type:
- Article
5
Clinical and pathological staging of the cancer at the nanoscale.
- Published in:
- Cancer Nanotechnology (1868-6958), 2012, v. 3, n. 1-6, p. 37, doi. 10.1007/s12645-012-0028-x
- By:
- Publication type:
- Article
6
Development of in vitro gene delivery system using ORMOSIL nanoparticle: Analysis of p53 gene expression in cultured breast cancer cell (MCF-7).
- Published in:
- Cancer Nanotechnology (1868-6958), 2012, v. 3, n. 1-6, p. 55, doi. 10.1007/s12645-012-0030-3
- By:
- Publication type:
- Article
7
Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin.
- Published in:
- Cancer Nanotechnology (1868-6958), 2012, v. 3, n. 1-6, p. 65, doi. 10.1007/s12645-012-0031-2
- By:
- Publication type:
- Article